Isoxazoline compounds as 5-lipoxygenase inhibitors

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/42 (2006.01) A61K 31/47 (2006.01)

Patent

CA 2184914

This invention relates to isoxazoline compounds which are inhibitors of 5-lipoxygenase (5-LO). The isoxazoline compounds are useful in the treatment or alleviation of inflammatory disease, allergy and cardiovascular diseases, wherein the inflammatory disease or condition is asthma, arthritis, bronchitis, chronic obstructive pulmonary disease, psoriasis, allergic rhinitis, dermatitis, shock, atopic dermatitis rheumatoid arthritis and osteoarthritis. This invention also relates to pharmaceutical compositions useful therefor.

L'invention se rapporte à des composés d'isoxazoline agissant comme inhibiteurs de 5-lipoxygénase (5-LO). Ces composés conviennent au traitement ou à l'atténuation des maladies inflammatoires, des allergies et des maladies cardiovasculaires, des troubles ou maladies inflammatoires comprenant notamment l'asthme, les bronchites, les bronchopneumopathies chroniques obstructives, le psoriasis, les rhinites allergiques, les dermatites, les chocs, les dermatites atopiques, la polyarthrite rhumatoïde et l'arthrose. L'invention se rapporte également à des compositions pharmaceutiques convenant à de tels traitements.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Isoxazoline compounds as 5-lipoxygenase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Isoxazoline compounds as 5-lipoxygenase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoxazoline compounds as 5-lipoxygenase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2009029

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.